Eastpharma Ltd GDR (LSE:63PE) - Share price - Overview

Stock Report

Eastpharma Ltd 63PE

Last Price
$-

Day Change
-|-%

As of -
- | USD
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap-
52-Wk Range-
Yield %-
ISINUS27778Q1058
Volume-
P/E-
P/S-
P/CF-

Share Price

Financials
201420152016
More ...
Income Statement
Revenue210.53209.89224.92
Operating Income16.3349.3940.85
Net Income-1.628.7015.37
Basic EPS-0.020.130.23
Avg. Diluted Shares Outstanding686868
Balance Sheet
Current Assets187.81170.36137.57
Non Current Assets323.19282.68259.75
Total Assets511.01453.05397.32
Current Liabilities116.50161.3573.85
Total Liabilities269.90256.14223.36
Total Equity241.10196.90173.96
Cash Flow
Operating Cash Flow18.3333.1354.99
Capital Expenditure-34.41-28.54-31.18
Free Cash Flow-16.074.5923.81

In millions, except "Basic EPS". Currency is USD.

Company Profile

Eastpharma Ltd is a pharmaceutical company engaged in manufacturing and marketing of branded and in-licensed generic pharmaceuticals in Turkey and other regional. It offers products including Azitro, Farlutal, Pantenol, Vi-Mineral, Amoklavin, and Madopar.

Sector

Healthcare

Industry

Drug Manufacturers - Major

Fiscal Year Ends

December

Employees

6
Key Stats
More ...
Price/Earning TTM-
Price/Book-
Price/Sales TTM-
Rev Growth (3 year avg)1.18
EPS Growth (3 year avg)-
Operating Margin % TTM18.16
Net Margin % TTM6.83
ROE TTM8.29
Debt/Equity0.37
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.